Citadel Advisors
TTPH

Citadel Advisors’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Citadel Advisors’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,213
Closed -$50K – 10057
2019
Q2 		$50K Sell
5,213
-69
-1% -$1.27K ﹤0.01% 8732
2019
Q1 		$142K Sell
5,282
-723
-12% -$18.4K ﹤0.01% 8405
2018
Q4 		$136K Sell
6,005
-2,937
-33% -$115K ﹤0.01% 8114
2018
Q3 		$494K Sell
8,942
-379
-4% -$24.2K ﹤0.01% 6726
2018
Q2 		$666K Buy
9,321
+6,772
+266% +$478K ﹤0.01% 5901
2018
Q1 		$157K Buy
2,549
+1,191
+88% +$105K ﹤0.01% 7513
2017
Q4 		$171K Buy
+1,358
New +$174K ﹤0.01% 7211
2017
Q2 		– Sell
-796
Closed -$146K – 8330
2017
Q1 		$146K Buy
796
+125
+19% +$14K ﹤0.01% 6705
2016
Q4 		$54K Sell
671
-609
-48% -$48.2K ﹤0.01% 6853
2016
Q3 		$98K Buy
+1,280
New +$103K ﹤0.01% 6661
2016
Q2 		– Sell
-2,189
Closed -$203K – 7667
2016
Q1 		$203K Buy
2,189
+698
+47% +$69.7K ﹤0.01% 5626
2015
Q4 		$299K Sell
1,491
-1,046
-41% -$209K ﹤0.01% 5224
2015
Q3 		$379K Sell
2,537
-16,619
-87% -$12.2M ﹤0.01% 5207
2015
Q2 		$18.2M Buy
19,156
+1,578
+9% +$1.29M 0.02% 1058
2015
Q1 		$12.9M Buy
17,578
+17,562
+109,763% +$13.2M 0.01% 1257
2014
Q4 		$12K Buy
+16
New +$8.61K ﹤0.01% 8082
2014
Q2 		– Sell
-996
Closed -$217K – 8469
2014
Q1 		$217K Buy
+996
New +$278K ﹤0.01% 5427

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors's TTPH Position: Q3 2019 in Review

Citadel Advisors sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2019, closing a stake of 5,213 shares — an estimated $50K sold.

Citadel Advisors first reported a position in TTPH in Q1 2014 and held it in 17 quarters. The position peaked at $18.2M in Q2 2015. 26 funds tracked by Wall St. Rank hold TTPH as of Q3 2019.

  • Citadel Advisors reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Citadel Advisors sold 5,213 Tetraphase Pharmaceuticals, Inc. shares in Q3 2019, an estimated $50K.
  • Citadel Advisors first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2014 and held it in 17 quarters.
  • Citadel Advisors's Tetraphase Pharmaceuticals, Inc. position peaked at $18.2M in Q2 2015.
  • 26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2019.

Based on Citadel Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.